These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 28032524)

  • 1. Classifying circulating tumor cells to monitor cancer progression.
    Economopoulou P; Georgoulias V; Kotsakis A
    Expert Rev Mol Diagn; 2017 Feb; 17(2):153-165. PubMed ID: 28032524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do circulating tumor cells, exosomes, and circulating tumor nucleic acids have clinical utility? A report of the association for molecular pathology.
    Gold B; Cankovic M; Furtado LV; Meier F; Gocke CD
    J Mol Diagn; 2015 May; 17(3):209-24. PubMed ID: 25908243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A headlight on liquid biopsies: a challenging tool for breast cancer management.
    Massihnia D; Perez A; Bazan V; Bronte G; Castiglia M; Fanale D; Barraco N; Cangemi A; Di Piazza F; Calò V; Rizzo S; Cicero G; Pantuso G; Russo A
    Tumour Biol; 2016 Apr; 37(4):4263-73. PubMed ID: 26790442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liquid biopsy: An emerging prognostic and predictive tool in Head and Neck Squamous Cell Carcinoma (HNSCC). Focus on Circulating Tumor Cells (CTCs).
    Economopoulou P; Kotsantis I; Kyrodimos E; Lianidou ES; Psyrri A
    Oral Oncol; 2017 Nov; 74():83-89. PubMed ID: 29103757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Applications of Circulating Tumor Cells and Circulating Tumor DNA as Liquid Biopsy.
    Alix-Panabières C; Pantel K
    Cancer Discov; 2016 May; 6(5):479-91. PubMed ID: 26969689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liquid biopsy: will it be the 'magic tool' for monitoring response of solid tumors to anticancer therapies?
    Gingras I; Salgado R; Ignatiadis M
    Curr Opin Oncol; 2015 Nov; 27(6):560-7. PubMed ID: 26335664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liquid biopsy in ovarian cancer: the potential of circulating miRNAs and exosomes.
    Giannopoulou L; Zavridou M; Kasimir-Bauer S; Lianidou ES
    Transl Res; 2019 Mar; 205():77-91. PubMed ID: 30391474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liquid Biopsy for the Management of Patients with Colorectal Cancer.
    Yamada T; Matsuda A; Koizumi M; Shinji S; Takahashi G; Iwai T; Takeda K; Ueda K; Yokoyama Y; Hara K; Hotta M; Matsumoto S; Yoshida H
    Digestion; 2019; 99(1):39-45. PubMed ID: 30554222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liquid Biopsies for Neuroendocrine Tumors: Circulating Tumor Cells, DNA, and MicroRNAs.
    Rizzo FM; Meyer T
    Endocrinol Metab Clin North Am; 2018 Sep; 47(3):471-483. PubMed ID: 30098711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances in circulating tumor cells and cell-free DNA in metastatic prostate cancer: a review.
    Parimi S; Ko JJ
    Expert Rev Anticancer Ther; 2017 Oct; 17(10):939-949. PubMed ID: 28737470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liquid biopsy and PCR-free ultrasensitive detection systems in oncology (Review).
    Finotti A; Allegretti M; Gasparello J; Giacomini P; Spandidos DA; Spoto G; Gambari R
    Int J Oncol; 2018 Oct; 53(4):1395-1434. PubMed ID: 30085333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating Tumor Cells as Cancer Biomarkers in the Clinic.
    Chinen LTD; Abdallah EA; Braun AC; Flores BCTCP; Corassa M; Sanches SM; Fanelli MF
    Adv Exp Med Biol; 2017; 994():1-41. PubMed ID: 28560666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liquid biopsy: ready to guide therapy in advanced prostate cancer?
    Hegemann M; Stenzl A; Bedke J; Chi KN; Black PC; Todenhöfer T
    BJU Int; 2016 Dec; 118(6):855-863. PubMed ID: 27430478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and validation of a multiplex methylation specific PCR-coupled liquid bead array for liquid biopsy analysis.
    Parisi C; Mastoraki S; Markou A; Strati A; Chimonidou M; Georgoulias V; Lianidou ES
    Clin Chim Acta; 2016 Oct; 461():156-64. PubMed ID: 27510924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of circulating tumor cells and circulating tumor DNA in non-small cell lung cancer: association with clinical endpoints in a phase II clinical trial of pertuzumab and erlotinib.
    Punnoose EA; Atwal S; Liu W; Raja R; Fine BM; Hughes BG; Hicks RJ; Hampton GM; Amler LC; Pirzkall A; Lackner MR
    Clin Cancer Res; 2012 Apr; 18(8):2391-401. PubMed ID: 22492982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating tumor cells in breast cancer--current status and perspectives.
    Banys-Paluchowski M; Krawczyk N; Meier-Stiegen F; Fehm T
    Crit Rev Oncol Hematol; 2016 Jan; 97():22-9. PubMed ID: 26563820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating tumor cells in lung cancer.
    Young R; Pailler E; Billiot F; Drusch F; Barthelemy A; Oulhen M; Besse B; Soria JC; Farace F; Vielh P
    Acta Cytol; 2012; 56(6):655-60. PubMed ID: 23207444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating tumor cells as promising novel biomarkers in solid cancers.
    Lianidou ES; Strati A; Markou A
    Crit Rev Clin Lab Sci; 2014 Jun; 51(3):160-71. PubMed ID: 24641350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monitoring tumor-derived cell-free DNA in patients with solid tumors: clinical perspectives and research opportunities.
    Esposito A; Bardelli A; Criscitiello C; Colombo N; Gelao L; Fumagalli L; Minchella I; Locatelli M; Goldhirsch A; Curigliano G
    Cancer Treat Rev; 2014 Jun; 40(5):648-55. PubMed ID: 24184333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating Tumor Cells and Circulating Tumor DNA: Challenges and Opportunities on the Path to Clinical Utility.
    Ignatiadis M; Lee M; Jeffrey SS
    Clin Cancer Res; 2015 Nov; 21(21):4786-800. PubMed ID: 26527805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.